跳轉至內容
Merck
全部照片(1)

重要文件

255165

Sigma-Aldrich

三丁基甲基氯化铵 溶液

75 wt. % in H2O

同義詞:

甲基三丁基氯化铵 溶液

登入查看組織和合約定價


About This Item

線性公式:
CH3N[CH3(CH2)3]3Cl
CAS號碼:
分子量::
235.84
MDL號碼:
分類程式碼代碼:
12352116
PubChem物質ID:
NACRES:
NA.22
暫時無法取得訂價和供貨情況

蒸汽壓力

7.9 mmHg ( 25 °C)

品質等級

濃度

75 wt. % in H2O

折射率

n20/D 1.4682

bp

152 °C

密度

0.964 g/mL at 25 °C

SMILES 字串

[Cl-].CCCC[N+](C)(CCCC)CCCC

InChI

1S/C13H30N.ClH/c1-5-8-11-14(4,12-9-6-2)13-10-7-3;/h5-13H2,1-4H3;1H/q+1;/p-1

InChI 密鑰

IPILPUZVTYHGIL-UHFFFAOYSA-M

一般說明

三丁基甲基氯化铵(TBMAC)是一种季铵盐,常用作各种有机合成反应的相转移催化剂[1]。也用于制备离子液体。[2] [3]

應用

三丁基甲基氯化铵溶液可作为相转移催化剂,用于在KHSO5氧化剂存在下,经由环己酮的Baeyer-Villiger氧化反应合成ɛ-己内酯。[1]

象形圖

Exclamation markEnvironment

訊號詞

Warning

危險分類

Acute Tox. 4 Dermal - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2

儲存類別代碼

10 - Combustible liquids

水污染物質分類(WGK)

WGK 2

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type ABEK (EN14387) respirator filter


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

New and efficient technique for the synthesis of ?-caprolactone using KHSO5 as an oxidising agent in the presence of a phase transfer catalyst
Baj S, et al.
Applied Catalysis A: General, 395(1-2), 49-52 (2011)
Enantioselective biocatalytic reduction of 2 H-1, 4-benzoxazines using imine reductases
Zumbra?gel N, et al.
The Journal of Organic Chemistry, 84(3), 1440-1447 (2018)
J W Smit et al.
The Journal of pharmacology and experimental therapeutics, 286(1), 321-327 (1998-07-10)
We recently showed that absence of mdr1-type P-glycoprotein (P-gp) in mice resulted in profoundly reduced hepatic and intestinal clearance of type 1 and type 2 cationic drugs compared with that in wild-type mice. These data strongly support the concept that
Soon-Sun Hong et al.
Archives of pharmacal research, 29(4), 318-322 (2006-05-10)
Many quaternary ammonium salts are incompletely absorbed after their oral administration and may also be actively secreted into the intestine. However, the underlying mechanism(s) that control the transport of these cations across the intestinal epithelium is not well understood. In
J E van Montfoort et al.
The Journal of pharmacology and experimental therapeutics, 298(1), 110-115 (2001-06-16)
Previous inhibition studies with taurocholate and cardiac glycosides suggested the presence of separate uptake systems for small "type I" (system1) and for bulky "type II" (system2) organic cations in rat hepatocytes. To identify the transport systems involved in type I

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務